Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Completed · Phase 1

Conditions studied: Actinic Keratosis

In brief

Study Hypothesis: Safety and Tolerability will differ when treating multiple contiguous 25 cm2 treatment areas, as compared to individual 25 cm2 treatment areas.

Key facts

Study ID
NCT00659893
Run by
Peplin
People needed
64
Starts
2008-04-01
Expected to finish
2008-11-01
Last updated by the study team
2015-09-14

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.